These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19237282)

  • 21. Imidazopyridines as VLA-4 integrin antagonists.
    Phillips DJ; Davenport RJ; Demaude TA; Galleway FP; Jones MW; Knerr L; Perry BG; Ratcliffe AJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4146-9. PubMed ID: 18539454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and characterization of a potent and selective antagonist of melanin-concentrating hormone receptor 2.
    Chen X; Mihalic J; Fan P; Liang L; Lindstrom M; Wong S; Ye Q; Fu Y; Jaen J; Chen JL; Dai K; Li L
    Bioorg Med Chem Lett; 2012 Jan; 22(1):363-6. PubMed ID: 22123324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of novel CCR2 antagonists: investigation of non-aryl/heteroaryl binding motifs.
    Trujillo JI; Huang W; Hughes RO; Rogier DJ; Turner SR; Devraj R; Morton PA; Xue CB; Chao G; Covington MB; Newton RC; Metcalf B
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1827-31. PubMed ID: 21316220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
    Chao J; Taveras AG; Chao J; Aki C; Dwyer M; Yu Y; Purakkattle B; Rindgen D; Jakway J; Hipkin W; Fosetta J; Fan X; Lundell D; Fine J; Minnicozzi M; Phillips J; Merritt JR
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3778-83. PubMed ID: 17459706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors.
    Van Huis CA; Bigge CF; Casimiro-Garcia A; Cody WL; Dudley DA; Filipski KJ; Heemstra RJ; Kohrt JT; Narasimhan LS; Schaum RP; Zhang E; Bryant JW; Haarer S; Janiczek N; Leadley RJ; McClanahan T; Thomas Peterson J; Welch KM; Edmunds JJ
    Chem Biol Drug Des; 2007 Jun; 69(6):444-50. PubMed ID: 17581239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-aminothiazole-gamma-aminobutanoic amides as potent, small molecule CCR2 receptor antagonists.
    Zhou C; Guo L; Parsons WH; Mills SG; MacCoss M; Vicario PP; Zweerink H; Cascieri MA; Springer MS; Yang L
    Bioorg Med Chem Lett; 2007 Jan; 17(2):309-14. PubMed ID: 17092717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists.
    Zappalà M; Pellicanò A; Micale N; Menniti FS; Ferreri G; De Sarro G; Grasso S; De Micheli C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):167-70. PubMed ID: 16216501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3).
    Kuduk SD; Chang RK; Wai JM; Di Marco CN; Cofre V; DiPardo RM; Cook SP; Cato MJ; Jovanovska A; Urban MO; Leitl M; Spencer RH; Kane SA; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4059-63. PubMed ID: 19553111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and SAR of tolylamine 5-HT6 antagonists.
    Singer JM; Wilson MW; Johnson PD; Graham SR; Cooke LW; Roof RL; Boxer PA; Gold LH; Meltzer LT; Janssen A; Roush N; Campbell JE; Su TZ; Hurst SI; Stoner CL; Schwarz JB
    Bioorg Med Chem Lett; 2009 May; 19(9):2409-12. PubMed ID: 19346128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.
    Ryckmans T; Edwards MP; Horne VA; Correia AM; Owen DR; Thompson LR; Tran I; Tutt MF; Young T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4406-9. PubMed ID: 19500981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.
    Holsworth DD; Jalaie M; Belliotti T; Cai C; Collard W; Ferreira S; Powell NA; Stier M; Zhang E; McConnell P; Mochalkin I; Ryan MJ; Bryant J; Li T; Kasani A; Subedi R; Maiti SN; Edmunds JJ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3575-80. PubMed ID: 17482464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and optimization of a novel Neuromedin B receptor antagonist.
    Fu J; Shuttleworth SJ; Connors RV; Chai A; Coward P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4264-7. PubMed ID: 19553112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
    Jin J; Wang Y; Shi D; Wang F; Fu W; Davis RS; Jin Q; Foley JJ; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Busch-Petersen J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5481-6. PubMed ID: 18818072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
    Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
    Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists.
    Pasternak A; Goble SD; Vicario PP; Di Salvo J; Ayala JM; Struthers M; DeMartino JA; Mills SG; Yang L
    Bioorg Med Chem Lett; 2008 Feb; 18(3):994-8. PubMed ID: 18164199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
    Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
    Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity.
    Lyne PD; Aquila B; Cook DJ; Dakin LA; Ezhuthachan J; Ioannidis S; Pontz T; Su M; Ye Q; Zheng X; Block MH; Cowen S; Deegan TL; Lee JW; Scott DA; Custeau D; Drew L; Poondru S; Shen M; Wu A
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1026-9. PubMed ID: 19097792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.